Fluorescent Visualization in Early Oral Cancer

Studies from Vancouver show that fluorescent visualization (FV) is a useful method of controlling surgical margins. This early finding will now be confirmed in a national randomized controlled trial.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Oral Squamous Cell Carcinoma or Severe Dysplasia Carcinoma Carcinoma, Squamous Cell Head and Neck Neoplasms Mouth Diseases Mouth Neoplasms Neoplasms Neoplasms by Histologic Type Neoplasms by Site Neoplasms, Glandular and Epithelial Squamous Cell Carcinoma of Head and Neck Stomatognathic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Foothills Hospital

Calgary, Alberta, T2N 4N1, Canada

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

biopsy proven invasive oral cancer or severe dysplasia / Cis
invasive cancer must be T1 or T2
no prior history of oral cancer / treatment of oral cancer

Exclusion criteria

prior history of oral cancer
unable to provide informed consent
lesion not able to be completely visualized by FV

Treatment and study plan

resection of oral cancer

Procedure

Oral cancer will be resected.

Primary outcomes

disease specific survival

Time frame: 5 years

disease specific 5 year survival

Sponsors and collaborators

Lead sponsor

University of Calgary

Other

Collaborators

Terry Fox Research Institute

Registry information

Important dates

Study start: 2011
Primary completion: 2017
Study completion: 2017
First posted: Dec 3, 2014
Registry last updated: May 2, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed